| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759548 Dialkyl-halogenophenyl-substituted ketoenols |
| 07/06/2004 | US6759428 Indole nitriles |
| 07/06/2004 | US6759427 Synthesis and methods of use of tetrahydroindolone analogues and derivatives |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759405 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 07/01/2004 | WO2004055026A1 Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 07/01/2004 | WO2004054972A1 N-(indolethyl-)cacloamine compounds |
| 07/01/2004 | WO2004026237A3 Compounds for the treatment of premature ejaculation |
| 07/01/2004 | WO2004024681A3 Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines |
| 07/01/2004 | WO2004014357A3 Therapeutic use of aryl amino acid derivatives |
| 07/01/2004 | WO2004014294A3 4,7-disubstituted indoles and methods of making |
| 07/01/2004 | WO2004005513A3 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 07/01/2004 | US20040127723 Process for preparing heterocyclic indene analogs |
| 07/01/2004 | US20040127658 Productivity catalysts and microstructure control |
| 07/01/2004 | US20040127565 Quarternary ammonium compounds |
| 07/01/2004 | US20040127560 compounds with high binding affinity for the glucagon receptor, such as: 3-{4-[1-(4-cyclohexylphenyl)-3-(3-trifluoromethoxyphenyl)ureidomethyl]benzoylamino}propionic acid; antidiabetic agents; antiobesity agent; antihypertensive agent |
| 07/01/2004 | US20040127546 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist |
| 07/01/2004 | US20040127545 Analogs of 2-phthalimidinoglutaric acid |
| 07/01/2004 | US20040127541 Bicifadine formulation |
| 07/01/2004 | US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 07/01/2004 | US20040127502 Use of pyrimidine compound galanin receptor subtype 3 (GAL3) antagonists, which may be classified as neutral antagonists, inverse agonists or allosteric modulators, to treat depressive disorders and/or anxiety |
| 07/01/2004 | US20040127365 Arylphenyl-substituted cyclic ketoenols |
| 07/01/2004 | US20040126700 Solvent solubility; quality film coatings; workability |
| 07/01/2004 | DE10259407A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis |
| 07/01/2004 | DE10259244A1 N-(Indolethyl-)cycloamin-Verbindungen N- (Indolethyl-) cyclo amine compounds |
| 07/01/2004 | CA2510169A1 N-(indolethyl-)cycloamine compounds |
| 06/30/2004 | EP1433779A1 Use of nitriles as inhibitors of non-proteolytic enzymes |
| 06/30/2004 | EP1433778A1 Use of nitriles as rotamase inhibitors |
| 06/30/2004 | EP1433479A1 Appetite-stimulating agents and remedies for anorexia |
| 06/30/2004 | EP1432734A1 Cytokine receptor |
| 06/30/2004 | EP1432701A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 06/30/2004 | EP1432681A1 Pseudopolymorphic forms of carvedilol |
| 06/30/2004 | EP1432680A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 06/30/2004 | EP1432428A1 Agent for colouring fibres containing keratin |
| 06/30/2004 | EP1432420A2 Benzimidazolidinone derivatives as muscarinic agents |
| 06/30/2004 | EP1432415A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases |
| 06/30/2004 | EP1385509A4 Method of treatment |
| 06/30/2004 | EP1149072B1 Sulfonamide hydroxamates |
| 06/30/2004 | EP0809629B1 2-phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides |
| 06/30/2004 | CN1509279A Process for production of citalopram |
| 06/30/2004 | CN1509270A Indolinons, substituted in position 6, and their preparation and use as kinase inhibitors |
| 06/30/2004 | CN1509165A Liquid pharmaceutical composition |
| 06/30/2004 | CN1508129A Method for synthesizing pyrrole amides |
| 06/30/2004 | CN1155596C New phenylpiperazines |
| 06/30/2004 | CN1155573C Fluorescent reagent 2-(N-carbazyl)-chlorethyl formate |
| 06/30/2004 | CN1155572C Indole derivatives and its anticancer usage |
| 06/30/2004 | CN1155571C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 06/30/2004 | CN1155570C Novel cyano-indole serotonin reextracted inhibitor compound, its preparation process and medicinal compositions having same |
| 06/30/2004 | CN1155569C Indolin derivs. as sun protection agents |
| 06/30/2004 | CN1155568C Method for producing 3-alkanoylindoles and 3-alkylindoles |
| 06/30/2004 | CN1155567C Antipsychotic indolyl derivatives |
| 06/29/2004 | US6756406 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines |
| 06/29/2004 | US6756398 Positive modulators of nicotinic receptor agonists |
| 06/29/2004 | US6756397 Such as (s)-n-(2-((1-chloromethyl)-1,2-dihydro-5-((4-methylpiperazino)carbonyloxy) -3h-benz(e) indol-3-yl)carbonyl)-1h-indol-5-yl)-5-((3-methyldithio-1-oxopropyl)-amino) -1h-indole-2-carboxamide; enhanced water solubility and stability |
| 06/29/2004 | US6756378 VLA-4 inhibitor compounds |
| 06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/24/2004 | WO2004052995A1 Process for the production of meso-substituted cyanine dyes |
| 06/24/2004 | WO2004052893A2 Substituted dihydropyrano indole-3,4-dione derivatives and 3-oxoacetic acid substituted 2-hydroxymethylindole derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052872A1 Haloalkene compounds, process for their production and pesticides containing them |
| 06/24/2004 | WO2004052857A1 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
| 06/24/2004 | WO2004052856A1 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052855A2 Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052854A2 Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052853A2 Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | WO2004052850A2 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052830A1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases |
| 06/24/2004 | WO2004024896A3 Phenyl-indole compounds |
| 06/24/2004 | WO2004022524A9 N-vinylformamide derivatives, polymers formed therefrom and synthesis thereof |
| 06/24/2004 | WO2004019869A3 Indoles having anti-diabetic activity |
| 06/24/2004 | WO2004011425A3 Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives |
| 06/24/2004 | WO2004005288A3 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | US20040122098 useful for treating conditions which arise from or are exacerbated by angiogenesis and also for treating cancer |
| 06/24/2004 | US20040122076 The use of 1-(iso)indolylsulfonamido-),4-(alkylamido-)benzenes and derivatives as 5-Ht6receptor antagonists; Alzheimer's disease; neurodegenerative diseases; prophylaxis |
| 06/24/2004 | US20040122070 Substituted 3-carbonyl-1H-indol-1-yl acetic acid derivatives for treating conditions resulting from fibrinolytic disorders, such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis; Alzheimer's disease |
| 06/24/2004 | US20040122063 Ethylenediamine derivatives |
| 06/24/2004 | US20040122040 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 06/24/2004 | US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide |
| 06/24/2004 | US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders |
| 06/24/2004 | CA2509242A1 Substituted dihydropyrano indole-3,4-dione derivatives and 3-oxoacetic acid substituted 2-hydroxymethylindole derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | CA2509238A1 Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | CA2509222A1 Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | CA2509191A1 Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | CA2509170A1 Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/24/2004 | CA2508619A1 Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 06/23/2004 | EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 06/23/2004 | EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 06/23/2004 | EP1430032A2 Substituted amides for the treatment of neurological disorders |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | EP1429757A2 Crystalline forms of fluvastatin sodium |
| 06/23/2004 | EP1353906B1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 06/23/2004 | EP1246817B1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 06/23/2004 | EP1066283B1 Substituted indolealkanoic acids |
| 06/23/2004 | CN1507441A Tricyclic alkylhydroxamates, their preparation and thier use as well proliferation inhibitors |
| 06/23/2004 | CN1506350A Process for producing N-(4-fluobenzene radical)-N-(2-hydroxy-4-chlorobenzene group) glycocoll |
| 06/23/2004 | CN1154634C 2-phenyl-substituted heterocyclic 1,3-keonols as herbicides and pesticides |
| 06/22/2004 | US6753429 1,4-disubstituted benzenes as insecticides |
| 06/22/2004 | CA2084137C Optically active bead polymers containing fillers |